| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |